Management of the Anticoagulated Patient with Life-Threatening Bleeding in the ED: An Interactive, Case-based Approach - Day 1
Wednesday, May 13th, 2020
12:00 p.m. – 1:00 p.m.
Room Location: Sliver Room- Mezzanine Level
|Arthur M. Pancioli, MD - University of Cincinnati - Indications for Anticoagulation and Agents: Coumadin, Factor IIa & Factor Xa Inhibitors|
Natalie P. Kreitzer, MD University of Cincinnati EM/Neurocritical Care, Intracranial and Intraspinal Bleeding in the Anticoagulated Patient
James W. Hoekstra, MD Wake Forest University, Treatment of Severe Gastrointestinal in the Anticoagulated Patient
|Gregory J. Fermann, MD - University of Cincinnati - |
Management of Life-Threatening Bleeding in the Anticoagulated ED PatientDisclosures: Speakers Bureau/Consulting: Janssen Pharmaceuticals; Research Support: Portola Pharmaceuticals
W. Brian Gibler, MD - University of Cincinnati (Moderator), Case PResentations/ AUdience Question and Answer/Panel Discussion.
Using a case-based, highly interactive approach with the Emergency Physician audience, this 1st day EMCREG-International Symposium will describe the indications for anticoagulation, pharmacologic agents, and reversal agents in the ED as well as emphasis on two major sources of severe bleeding with significant morbidity and mortality – intracranial/intraspinal bleeding and gastrointestinal bleeding.
At the conclusion of this symposium, attendees will be able to:
1) Describe the indications for anticoagulation and agents including coumadin, Factor IIa, and Factor Xa inhibitors;
2) Identify and integrate the management of the anticoagulated patient in the ED and ICU; and
3) Compare and contrast the treatment of intracranial, intraspinal, and gastrointestinal bleeding in the anticoagulated patient.
The University of Cincinnati College of Medicine Office of Continuing Medical Education is accrediting this 1 hour symposium for 1 (one) hour of Category 1 ACCME credit.